Molecular Partners AG -ADRMOLN
13F holders, Q1 2025 (March 31)6holders +1
1new positions
0sold out
$3.95avg. 13F price*
At the end of Q1 2025, 6 institutions reported holding Molecular Partners AG -ADR (MOLN) in their 13F filings, up 1 from Q4 2024. 1 opened new positions and 0 sold out. The largest holders were Montanova Capital, LLC ($8.6M), BVF Inc. ($5.5M) and UBS Group AG ($25K).
- Company
- Molecular Partners AG -ADR
- CUSIP
- 60853G106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $609 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 157 shares bought and 521 shares sold, net −364 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Montanova Capital, LLC | 0.35% | No change | 2,221,494 | $8.6M |
| BVF Inc. | 0.22% | No change | 1,353,968 | $5.5M |
| UBS Group AG | 0.00% | Reduce -7.6% | 6,351 | $25K |
| Morgan Stanley | 0.00% | No change | 367 | $1K |
| Rhumbline Advisers | 0.00% | No change | 269 | $1K |
| Bank of America Corp. | 0.00% | New | 157 | $609 |
"% of holder's portfolio" is MOLN's weight in each manager's 13F, not the share of Molecular Partners AG -ADR the manager owns.